000739 Apeloa Pharmaceutical
- 16.27
- -0.37-2.22%
Apeloa Pharmaceutical News
Prologis Pharmaceutical: Announcement on the expiration of the share repurchase period and the implementation results of the repurchase
Prologis Pharmaceuticals: Progress Announcement on the Repurchase of the Company\'s Shares
Apeloa Pharmaceutical: Announcement regarding the progress of repurchasing company shares.
Apeloa Pharmaceutical: Announcement regarding the progress of repurchasing company shares.
Apeloa Pharmaceutical: Announcement on the completion of share repurchase cancellation and changes in shareholding
Apeloa Pharmaceutical: Announcement regarding the progress of repurchasing company shares.
Apeloa Pharmaceutical: 2023 dividend payment implementation announcement
Apeloa Pharmaceutical: Announcement on the progress of the repurchase of company shares
Prologis Pharmaceuticals: Announcement on the initial repurchase of the company's shares
Prologis Pharmaceutical: Announcement on the shareholding status of the top ten shareholders and the top ten shareholders with unlimited sales conditions for share repurchases
Prologis Pharmaceuticals: Report on share repurchase
Prologis Pharmaceutical: Announcement on the pledge of part of the company's controlling shareholder
Prologis Pharmaceuticals: Announcement on the plan to repurchase the company\'s shares
Prologis Pharmaceutical: Announcement on the cancellation of the company's controlling shareholder's share pledge
Prologis Pharmaceuticals: Announcement on the 2023 Profit Distribution Plan
Prologis Pharmaceuticals: Progress Announcement on the Continued Separation of Shareholders and Changes in Equity of 5% or More
Proluo Pharmaceutical: Prompt Announcement on the Continuation of Separation and Changes in Equity of 5% or More Shareholders
Proluo Pharmaceutical: Prompt Announcement on the Imminent Expiration of the First Phase of the Employee Stock Ownership Plan
Prologue Pharmaceutical: 2022 Annual Equity Distribution Implementation Notice
Proluo Pharmaceutical: Announcement on participation in the subscription for the non-public offering of A-shares by Suzhou Zejing Biopharmaceutical Co., Ltd.
No Data
